ukactive and CIMSPA release weight medication guidance for sector

ukactive and CIMSPA have published guidance to help support the sport and physical activity sector better understand the use of weight management medications within the market.

Titled ‘Guidance for sport and physical activity on understanding the use of weight management medications’, the resource is designed to support best practice and to help foster collaboration with healthcare providers to deliver holistic and sustainable health improvements. It includes sections on understanding weight management medication, key areas of knowledge for the sector’s workforce, practical and ethical considerations, and advice for educational partners. There is also guidance on signposting to accredited healthcare professionals, who decide what is most appropriate for an individual to take, in discussion with patients, and considering relevant clinical guidance.

The document has been informed by evidence-based research and consultation with healthcare experts and professionals from the Royal College of General Practitioners (RCGP), Bodyline Medical Wellness Clinics and All About Obesity.

The guidance forms part of the ukactive and CIMSPA’s commitment to develop tailored guidance for facility operators, giving them the confidence to welcome and support members taking weight-loss medications safely.

The two organisations will continue to work closely with experts to monitor the roll out and impact of weight-loss medications and the operational implications for the sector.

Kenny Butler, Strategic Lead, Health & Wellbeing at ukactive, said: “Like any chronic, long-term condition, managing obesity can be complex, so this guidance will help operators of gyms, health clubs, pools and leisure centres to support people using weight-loss drugs.”